Alphatec announced that it acquired all assets related to the REMI robotic navigation system from Fusion Robotics.
Auris Health, an Ethicon subsidiary, received FDA clearance for Monarch for endourological procedures in May 2022.
Ronovo Surgical announced that it closed a new round of financing, bringing its total funds raised to more than $50 million since 2020.
New features from Asensus Surgical include 3D measurement, digital tagging and image enhancement.
Intuitive Surgical released preliminary Q4 results that included a revenue miss, but the company expects da Vinci surgical robot procedures to grow.
Siemens Healthineers acquired Corindus for $1.1 billion in 2019. Corindus develops the CorPath robot-assisted device for coronary and peripheral vascular procedures.
Titan Medical announced today that it plans to review and evaluate strategic alternatives to unlock shareholder value.
Through magnetic propulsion, the company’s Bionauts can navigate the human body and deliver drugs locally.
Surgical robotics company described share consolidation as the last option to regain compliance with Nasdaq’s $1 per share minimum bid price requirement and retain its listing.
Robotic microsurgery company Medical Microinstruments announced today that it raised $75 million in a Series B financing round.
The latest generation of the Ekso Bionics platform, the EksoNR previously received clearance for stroke and spinal cord rehabilitation in 2016, then acquired brain injury (ABI) in 2020
The Xact Ace system combines image-based procedure planning and real-time monitoring with hands-free precise robotic insertion and non-linear steering.
Worldwide procedures performed with the da Vinci surgical robot increased 19% compared to the fourth quarter of 2020.
Memic’s Hominis system will be used in single-site, natural orifice laparoscopic-assisted transvaginal benign gynecological procedures.
OrthoSpin’s robot-assisted external fixation system for orthopedic treatments is a platform used in DePuy Synthes’ Maxframe.
Medtronic’s rollout of their Hugo robotics assisted surgical robot will be delayed due to supply-chain issues.
Myomo said this is a 128% increase year over year and the highest quarterly revenue in the company’s history.
J&J said the system is being delayed due to technical development challenges and COVID-19-related disruptions, including supply chain constraints.
The CE mark covers urologic and gynecologic procedures, which make up approximately half of all robotic procedures performed today, according to the company.
NuVasive said clinical evaluations for Pulse are now underway across multiple countries throughout Europe.
The procedure marks the beginning of the Hugo system patient registry, which will collect clinical data as Medtronic seeks regulatory submissions.
Memic develops Hominis, the first FDA approved, robotically-assisted surgical device for transvaginal hysterectomies.